ClinicalTrials.gg
CompletedNCT05080036SM01Updated Oct 17, 2022

Muscle Activation of the Lower Limb in Response to a Medio-lateral Imbalance in Monopodal Stance

An interventional study of Medio-lateral imbalance in Healthy, sponsored by Manusapiens. Completed at 1 site in Italy. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-17.

Sponsored by Manusapiens · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The "static" single-leg stance has been extensively studied in the literature for its relevance in functional evaluation, therapeutic exercise, sports training and research for fall prevention (particularly for the elderly and patients with neurological diseases). However, the motor strategies of the supporting limb have been investigated only at the ankle level. In particular it is not known, at the hip, how the muscular system reacts to medial and lateral imbalances. Colonna has hypothesized, basing on a myofascial chains approach, that the balance is managed by the front and back spiral chains. The aim of the present study is to perform a preliminary experimental analysis to verify Colonna's hypothesis, testing a method for the investigation of motor strategies underlying equilibrium.

Five healthy subjects will be examined by means of electromyographic analysis of the gluteus maximus, gluteus medius, adductor longus, tibialis anterior and peroneus longus. Subjects will undergo perturbations of their monopodal balance.

Read the detailed description

The subjects involved in the research will be analyzed at the LAMBDA laboratory (UDGEE), AUSL-IRCCS (Azienda Unità Sanitaria Locale-Istituto di Ricovero e Cura a Carattere Scientifico) di Reggio Emilia.

The analysis will be carried out on the right lower limb of each subject. The electromyographic devices will be applied to the tibialis anterior, peroneus longus, gluteus medius, gluteus maximus and adductor longus.

Reflective markers will then be applied (using double-sided tape) according to the Total3DGait protocol, which identifies the body segments of the forearms, arms, trunk, pelvis, thighs, legs, and feet.

The subject must position himself with his right foot on a force platform. The toe of the left foot will be allowed to rest on the ground (on the other power platform posteriorly placed), with the verbal indication to load as little weight as possible on it: this indication is aimed at reducing muscle activation in the absence of external perturbations, in order to highlight only the activity caused by the perturbations themselves. Only acquisitions in which the load on the left foot will be less than 30% of the weight will be considered valid.

The hands will be placed on the hips to limit the variables to be controlled and to standardize the posture, in order to focus the contribution to the balance of the lower limb. The left thigh has to be kept vertical. Finally, it will be required to find, within the constraints described above, the posture that is as comfortable as possible, with minimal muscle contraction. The distance between the feet is therefore freely chosen by each subject.

The operator positions himself behind the subject to be examined, and without being seen performs lateral thrusts with the medial margin of the hand at the proximal third of the thigh. At least ten pushes per side will be performed, with random timing. The thrusts will be quick but without causing pain.

The operator will then request maximal contractions from the subject, in order to normalize the electrical activity of each muscle with respect to its maximum. It will be required to perform the dorsiflexion and pronation of the foot against resistance, then the adduction, abduction and extension of the hip.

02

Conditions studied

  • Healthy

Keywords

  • human balance
  • monopodal stance
  • electromyography
  • myofascial chains
03

In context

Lead sponsor

Manusapiens is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All healthy subjects

Exclusion criteria

Exclusion Criteria:

  • skeletal pathologies compromising balance
  • neuromotor pathologies compromising balance
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Unbalanced healthy subjects

    Subjects undergo an external perturbation of their balance

    Other: Medio-lateral imbalance

Interventions

  • OtherMedio-lateral imbalance

    Thrust on the pelvis in the medio-lateral direction in order to create a balance perturbation

06

What researchers measure

Primary outcomes

  1. Maximum electrical intensity during early response of muscle activation

    The muscles considered will be, for the anterior spiral chain, the adductor longus and the peroneus longus, for the posterior spiral chain, the glutei (medius and maximus) and the tibialis anterior. For each muscle, the intensity will be normalized to the intensity of the maximal contraction. Muscle activity will be evaluated for 1500ms, 500ms before and 1000ms after the thrust. The early response to the stimulus will be identified in the interval of 100-500ms after the thrust.The thrusts will be performed 10 times towards the medial direction and 10 towards the lateral. The median intensity for each direction will be calculated.

    Time frame: During the procedure

  2. Correlation of muscle activity

    Correlation coefficients of the activation intensity between each muscle of the hip and each muscle of the ankle: tibialis anterior-glutei; tibialis anterior-adductor longus; peroneus longus-glutei; peroneus longus-adductor longus. Calculated for each imbalance direction.

    Time frame: During the procedure

07

Study locations

1 site
  • AUSL-IRCCS di Reggio Emilia
    Reggio Emilia, 42122, Italy
08

References and documents

Publications

  • Colonna S., 2012. Le catene miofasciali in medicina manuale - Arto inferiore: Ginocchio, Ed. Martina.
  • Morey-Klapsing G, Arampatzis A, Bruggemann GP. Joint stabilising response to lateral and medial tilts. Clin Biomech (Bristol). 2005 Jun;20(5):517-25. doi: 10.1016/j.clinbiomech.2005.01.008. PubMed 15836939 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2021 to primary completion in Nov 2021, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2021
First posted
Oct 15, 2021
StartActual
Aug 1, 2021
Primary completionActual
Nov 1, 2021
CompletionActual
Dec 30, 2021
Last update
Oct 17, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 17, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05080036
Lead sponsor
Manusapiens
Responsible party
Sponsor
First posted
Oct 15, 2021
Start date
Aug 1, 2021
Primary completion
Nov 1, 2021
Completion
Dec 30, 2021
Last update
Oct 17, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion